title: [The prevention of recurrences of surface bladder cancer by BCG vaccinal immunotherapy].
authors.forename: B P
authors.initials: BP
authors.lastname: Matveev
authors.forename: O B
authors.initials: OB
authors.lastname: Kariakin
authors.forename: K N
authors.initials: KN
authors.lastname: Safiullin
authors.forename: K M
authors.initials: KM
authors.lastname: Figurin
authors.forename: D T
authors.initials: DT
authors.lastname: Levi
authors.forename: O E
authors.initials: OE
authors.lastname: Vatin
mesh_terms: D000283:Administration, Intravesical; D000328:Adult; D000368:Aged; D001500:BCG Vaccine / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D016233:Immunotherapy, Active / Q000379:methods*; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000276:immunology / Q000517:prevention & control*; D011182:Postoperative Care; D012074:Remission Induction; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000276:immunology / Q000517:prevention & control*
chemical_list: D001500:BCG Vaccine
vernacular_title: Profilaktika retsidivov poverkhnostnogo raka mochevogo puzyria immunoterapieĭ vaktsinoĭ BTsZh.